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In vivo monitoring of intracellular Ca2+ dynamics in the pancreatic β-cells of
zebrafish embryos
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Maria S. Remedi b,d, Colin G. Nichols b,c, and Dirk Meyer a
aInstitute of Molecular Biology/CMBI, University of Innsbruck, Innsbruck, Austria; bDepartment of Cell Biology and Physiology, Washington
University School of Medicine, St. Louis, MO, USA; cCenter for the Investigation of Membrane Excitability Diseases (CIMED), Washington
University School of Medicine, St. Louis, MO, USA; dDepartment of Medicine, Washington University School of Medicine, St. Louis, MO, USA
ABSTRACT
Assessing the response of pancreatic islet cells to glucose stimulation is important for under-
standing β-cell function. Zebrafish are a promising model for studies of metabolism in general,
including stimulus-secretion coupling in the pancreas. We used transgenic zebrafish embryos
expressing a genetically-encoded Ca2+ sensor in pancreatic β-cells to monitor a key step in
glucose induced insulin secretion; the elevations of intracellular [Ca2+]i. In vivo and ex vivo analyses
of [Ca2+]i demonstrate that β-cell responsiveness to glucose is well established in late embry-
ogenesis and that embryonic β-cells also respond to free fatty acid and amino acid challenges. In
vivo imaging of whole embryos further shows that indirect glucose administration, for example by
yolk injection, results in a slow and asynchronous induction of β-cell [Ca2+]i responses, while
intravenous glucose injections cause immediate and islet-wide synchronized [Ca2+]i fluctuations.
Finally, we demonstrate that embryos with disrupted mutation of the CaV1.2 channel gene
cacna1c are hyperglycemic and that this phenotype is associated with glucose-independent
[Ca2+]i fluctuation in β-cells. The data reveal a novel central role of cacna1c in β-cell specific
stimulus-secretion coupling in zebrafish and demonstrate that the novel approach we propose –
to monitor the [Ca2+]i dynamics in embryonic β-cells in vivo – will help to expand the under-
standing of β-cell physiological functions in healthy and diseased states.
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Introduction
Assessing the response of pancreatic islet cells
to glucose stimulation is important for under-
standing β-cell function in healthy and diseased
states. Until now, pancreatic β-cell physiology
has been analyzed mainly in isolated cell and
islet systems.1–5 Importantly, β-cells under
these conditions likely exhibit different physiol-
ogy when compared to cells in their natural in
vivo environment. A key step in mammalian
glucose-stimulated insulin secretion is the ele-
vation of intracellular [Ca2+]i. Non-invasive in
vivo imaging of [Ca2+]i has recently been facili-
tated by transplantation of pancreatic islets into
the anterior chamber of the eye or the kidney
capsule of mice. Such real-time monitoring
facilitates the study of islet physiology and vas-
cularization longitudinally, and enables in vivo
screening of novel drugs and treatments.6
Ultimately, however, it is desirable to incorpo-
rate in vivo imaging of native intracellular [Ca2
+]i without interfering with the complex para-
crine signalling networks regulating islet activ-
ity in native tissue (for a review, see ref.7) Here
we tested transgenic zebrafish embryos expres-
sing a genetically encoded Ca2+ sensor in their
β-cells as a potential model for corresponding
non-invasive in vivo applications. Non-mam-
malian vertebrates such as zebrafish (Danio
rerio) have become relevant alternative organ-
isms to study diabetes and other metabolic
diseases,8 due to ease of genetic manipulation,
high reproduction rates, and ready access for in
vivo imaging due to larval transparency.
Importantly, pancreata in mammals and in zeb-
rafish have conserved physiological endocrine
and exocrine function, similar cellular architec-
ture, and conserved expression and function of
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most developmental genes.9 Accordingly, the
zebrafish has proven highly productive for stu-
dies of pancreas development,10–12 and
regeneration.13,14 In mammals as well as in
zebrafish the pancreas develops from the endo-
dermal germ layer and later compromises endo-
crine and exocrine tissue.15 Within one day of
development, the zebrafish embryo forms a sin-
gle ‘primary’ pancreatic islet with ~60–70
mono-hormonal α-, β-, δ-, ε-cells. As develop-
ment proceeds, the primary islet increases in
size and additional secondary islets are formed,
to adopt to growth-related requirements.
Glucose metabolism in zebrafish is also very
similar to mammalian glucose metabolism, and
overfed zebrafish displays obesity-related diabetes
phenotypes including impaired glucose tolerance
and increased insulin production.16 The molecular
basis of glucose detection is well understood in
mammalian pancreatic β-cells (for a review, see
ref.17 and.18) Glucose is taken up by the facilitative
glucose transporter (GLUT) GLUT2/SLC2A2, and
is metabolized through glycolysis and oxidative
phosphorylation, thereby generating adenosine tri-
phosphate (ATP) and increasing the ATP/ADP
ratio.11,19 The altered [ATP/ADP] ratio in the β-
cell then leads to the closure of ATP-sensitive K+-
channels (KATP-channels), depolarization of the
membrane, and consequent opening of voltage-
dependent calcium channels (VDCCs).20 The
influx of Ca2+ then triggers release of insulin
from secretory granules.21 Orthologues of all
major genes (GLUT, KATP-channels and VDCCs)
involved in mammalian glucose sensing and insu-
lin secretion are also expressed in zebrafish, and
show functional similarities.22–25 Studies suggest
that glucose uptake in zebrafish, similar to mam-
mals, occurs through GLUT transporters, with
GLUT2 expression found in the endocrine pan-
creas of zebrafish larvae.26,27 Furthermore, we and
others recently demonstrated that zebrafish islet β-
cells express functional KATP channels with con-
served structure and metabolic sensitivity to their
mammalian counterparts, supporting the use of
zebrafish as a model animal in islet glucose sensing
and diabetes research.28,29
Excitability of β-cells has been investigated by
multiple strategies including monitoring of the
membrane potential by electrical recordings, and
using Ca2+-sensitive dyes.30–32 More recently,
genetically encoded Ca2+ indicators have been
introduced as tools for non-invasive approaches to
study excitable cells such as β-cells. The analysis of
Ca2+ transients in corresponding models systems
will help in understanding underlying causes of β-
cell dysfunction (for example in the context of
diabetes risk factors.33,34) In vivo imaging of [Ca2
+]i dynamics in transplanted (intraocular) mouse
pancreatic islets showed reduction at a prediabetic
stage, suggesting the potential of [Ca2+]i as a func-
tional marker to evaluate β-cells in vivo in diseased
states.35 Nevertheless, the low litter numbers, com-
plicated methodologies, high costs, and large
experiment variability limit the use of mammalian
species for such studies. Since genetic manipulation
is easy and inexpensive in transparent zebrafish
larvae, large-scale drug and genetic screens as well
as fluorescent imaging applications for studying β-
cell physiology in living animals are feasible.36–38
Monitoring of the glucose-stimulated Ca2+ influx in
isolated juvenile and larvae zebrafish islets has been
previously described.39 We recently generated a
transgenic line expressing the genetically encoded
Ca2+-sensor GCaMP6s, and in this study we have
established protocols for in vivo monitoring of [Ca2
+]i dynamics in late embryonic animals. We found
that β-cells in larvae show rare baseline sponta-
neous activities, but after intravenous injections of
glucose, virtually all β-cells showed very rapid ele-
vations in GCaMP6s fluorescence.
Additionally, we have used the GCaMP6s
reporter to assess β-cell associated function of
VDCCs. β-cell specific CaV1.2
−/- mice exhibit
mild basal hyperglycemia, impaired glucose tol-
erance and lack of first-phase insulin secretion,-
40,41 but this important role in mammalian
glucose-induced insulin secretion has not been
assessed in zebrafish.40–43
Results
Zebrafish β-cell [Ca2+]i responses depend on the
route of glucose administration in vivo
To enable in vivo studies of β-cell [Ca2+]i in
zebrafish larva, we generated a transgenic line
expressing a genetically encoded membrane-
tagged Ca2+-sensor together with a Histone-
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tagged RFP, both under control of the insulin
promoter (Tg[ins:lynGCaMP6s; ins:H2B-RFP],
referred to hereafter as ins:lynGCaMP6s;
Figure 1(A,B)). The combined expression of
lynGCaMP6s and H2B-RFP in β-cells enabled
rapid β-cell identification and measurements of
Ca2+ responses in selected β-cell areas. We
further established protocols for determining
β-cell specific Ca2+ changes either in the living
embryo (Figure 1(C)) or in isolated islets
(Figure 1(D)). In the first set of experiments,
we recorded β-cell responses to different routes
of glucose administration. To simulate physio-
logically relevant feeding-related gradual and
continued increase of blood glucose level, we
tested injections of glucose into the yolk, the
Figure 1. Specific expression of GCaMP6s sensor in pancreatic β-cells enables the study of Ca2+ fluxes in live zebrafish.
(A) Illustration of the construct used to generate Tg[ins:lynGCaMP6s ins:H2BtagRFP] (ins:lynGCaMP6s). The GCaMP6s sensor was
linked N-terminal with a lyn membrane tag. The additional ins:H2BtagRFP sequence was added to the construct to ease the
screening of transgenic embryos and to identify the β-cells due to the nuclear specific H2BtagRFP signal. (B) Antibody staining on
5 days post fertilization (dpf) ins:lynGCaMP6s embryos detecting >95% overlapping of endogenous insulin and GCaMP6s (using
polyconal GFP antibody) and >80% overlapping of H2B:RFP and GCaMP6s (n = 12 larvae, 20 β-cells per larva were analysed). (C)
Schematic outline of intravenous glucose injection of zebrafish larvae. Using α-bungarotoxin (BTX) protein injection, the zebrafish
larvae are paralyzed. After 10–15 min, the larvae are embedded in low melt agarose. Using a micromanipulator assembled to the
microscope, glucose (in combination with Rhodamine B isothiocyanate-Dextran) is injected to the dorsal aorta of the embryo while
the imaging is running. (D) Schematic outline of perfusion system on extracted pancreatic islet of zebrafish embryos. Islets from ins:
lynGCaMP6s fish are isolated and placed into glass-bottomed culture plates with agarose gel wells containing islet media for Ca2+
imaging as solutions are changed. Scale bar = 10 µm
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pericardium or the hindbrain ventricle. In all
approaches, the glucose injection induced Ca2+
fluctuation in β-cells (Sup. Fig. 1D–F), but the
responses were very variable, with delays
between injection and response ranging from
seconds to minutes and the number of
responsive cells varying from 5–30% (Sup.
Fig. 1A–C). In contrast, intravenous injection
of D-glucose (~10–20 mM final concentration)
in wild-type 5 dpf larvae evoked rapid and
robust elevations in the GCaMP6s fluorescence
in almost all labelled cells (Figure 2(A), blue
Figure 2. Zebrafish β-cells show rapid glucose response in vivo.
(A) In vivo experiments in larva revealed rapid fluorescence signal alteration (peak within 5 sec) in response to intravenous injection
of >10 mM D-glucose (blue line) (5 dpf) (n = 8 larvae). To confirm that the response is due to D-glucose metabolism, L-glucose (red
line) using same concentration (>10 mM) was also injected and showed no response (n = 5 larvae). (B) Fluorescence image series of
the islet showing β-cell specific GCaMP6 signal at the indicated time-points (sec) after intravenous injection of D-glucose (>10 mM
final concentration) in 5 dpf larva. Scale bar = 10 µm (C) Quantitative GCaMP6 signal intensity in the larvae shown in (B), and two
other individual larvae (gray dotted lines), showing calcium influx after sequential glucose injections (1.injection: >10 mM, 2.
Injection: >20 mM, 3. Injection: >30 mM estimated final concentration). FIU intensities for the whole islet were determined using
Image-J and normalized to the FIU baseline (intensity measured in the first time point). (D) Representative fluorescence traces of
manually selected β-cell areas (n = 4, based on red RFP expression as indicated) in a 5 dpf old zebrafish larva, normalized to initial
fluorescence intensity, while 1–2 nl of 0.5 M D-glucose (>10 mM final concentration) was intravenously injected in vivo (at dotted
black line). After glucose injection β-cell areas show oscillation. (E) Cross-correlation matrix (determined by PeakCaller, MATLAB) of
the 4, in (D) indicated, β-cell areas after intravenous glucose injection. The panel represent one islet with 4–4 cell comparison. Colour
map key is given to the right of the panel. Further examples are shown in Sup. Fig. 2B. FIU = Fluorescence Intensity Units (AU,
Arbitrary Units).
224 R. LORINCZ ET AL.
line). Sequential intravenous glucose injections
resulted in repeated similar rapid responses, but
the normalized Fluorescence Intensity Unit
(FIU) peaks decreased after the second and
third injection (Figure 2(B,(C)). Control injec-
tions with the same concentration of L-glucose
caused no GCaMP6s signals (Figure 2(A), red
line), confirming that the response is due to
glucose metabolism, rather than osmotic stress
or other potential injection artefacts. In intra-
venously D-glucose-injected embryos, the fluor-
escence increased almost immediately after
injection, and reached its peak within 5 seconds,
followed by oscillations across the islets (5 ± 1
peaks/minute; Figure 2(D), Sup.Video 1 and 2).
Correlation analyses revealed that glucose-
induced responses are synchronized across the
islet when the glucose is injected intravenously
(Figure 2(E) and Sup. Fig. 2B), which was not
the case for yolk injection (Sup. Fig. 2C), indi-
cating that the in vivo responsiveness of zebra-
fish β-cells to glucose depends on the route of
glucose administration.
Zebrafish islets are glucose responsive in early
developmental stages
We next assessed whether the glucose-responsive-
ness of β-cells observed in 5 dpf larvae is also seen
at earlier developmental stages. Studies in rodents
have established that islet maturity and function
vary during development, with glucose responsive-
ness occurring in later stages, particularly near the
weaning transition.44 Previous studies showed that
insulin-dependent glucose homeostasis in zebra-
fish starts at 3 dpf.45 Normalized FIU intensities
showed similar glucose-induced [Ca2+]i dynamics
over time (Figure 3(a)), and quantification of the
GCaMP6s signal revealed significantly higher peak
FIU intensities after glucose injection compared to
baseline (before glucose), but no significant differ-
ences between developmental stages (3, 4 and
5 dpf) (Figure 3(b)). In addition, little or no spon-
taneous responses were observed in unstimulated
larvae at 3–5 dpf (Figure 3(c,d)). This shows that
the embryonic onset of insulin-dependent glucose
homeostasis correlates with the requirement for
glucose-sensing mechanisms after 3 dpf.
Zebrafish islets are uncoupled ex vivo
To assess the concentration-dependence of glucose
and other nutrients on β-cell excitation, we per-
formed perfusion studies with isolated pancreatic
islets (ex vivo) from 5 dpf old zebrafish larvae
(Figure 1(D)). Isolated larval islets were first incu-
bated in 2 mM glucose solution, then stimulated
with 20 mM glucose solution and at the end of the
recording, 30 mM KCl solution was applied to
confirm excitability. In these experiments, higher
resolution imaging by spinning disc microscopy
enabled single cell analysis of the isolated islets.
Consistent with the in vivo data, 20 mM glucose
increased GCaMP6s FIU/FIU baseline intensity
(Figure 4(A,B)), almost all β-cells (83% ± 24%,
Figure 4(C)) responded to the glucose stimulus,
and the induced [Ca2+]i oscillated with similar
frequencies (5 ± 1 and 6 ± 1 peaks/minute, respec-
tively, Figure 4(D)). However, in contrast to what
was observed after intravenous glucose injection,
ex vivo β-cell responses were out of phase (correla-
tion analyses shown Figure 4(E,C), Sup. Fig. 3 and
2B). Notably, the time to peak in the ex vivo
studies were highly variable (ranging from a few
seconds to minutes) and on average were more
than 30 times longer than those seen after intra-
venous glucose injection (4.4 ± 0.5 sec in vivo and
140 ± 30 sec ex vivo, Figure 4(F)).
L-glutamine and palmitic acid also stimulate
[Ca2+]i influx in zebrafish pancreatic islet
In mammalian β-cells, excitation occurs not only
in response to glucose but also to various other
stimuli. 46–49 To test whether amino acids and free
fatty acids contribute to [Ca2+]i signalling of zeb-
rafish pancreatic islets, perfusion experiments with
L-glutamine and palmitic acid on extracted islets
were carried out. Whole islets extracted from 5 dpf
zebrafish larvae showed increase in GCaMP6s
FIU/FIU baseline intensity when 20 mM
L-glutamine or 1 mM palmitic acid alone and no
glucose was applied in the perfusion system
(Figure 5(A,B)). To confirm that the responses
were specific to the nutrients and were not due
to osmotic stress, we performed perfusion experi-
ments with 20 mM sucrose on the extracted pan-
creatic islet; no significant increase in GCaMP6s
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fluorescence intensity was observed. In all cases,
islets were excitable, as revealed by the change in
fluorescence upon 30 mM KCl stimulation
(Figure 5(C)). Again, Ca2+ fluctuations occurred
asynchronously across the whole islet in all ex vivo
conditions, indicating that β-cells were not
coupled with one other (Figure 5(A,B), right
panels). These results revealed that short-term
exposure to L-glutamine alone or to palmitic
acid, without glucose, stimulates [Ca2+]i influx in
embryonic zebrafish pancreatic islets.
Cav1.2/isl
m458 mutant zebrafish are
hyperglycemic
Next we used the ins:lynGCaMP6s reporter to
assess β-cell specific defects in L-type calcium
channel mutant zebrafish embryos. Currently, the
Figure 3. Similar in vivo glucose responses in 3 dpf, 4 dpf and 5 dpf zebrafish larvae.
(A) Quantitation GCaMP6 signal intensity show rapid fluorescence signal alteration after intravenous injection of D-glucose (>10 mM
final concentration) in 3, 4 and 5 dpf larvae (n = 5, 3 and 8 larvae, respectively), (C) and no or little alteration in unstimulated larvae
(n = 8, 8 and 6 larvae, respectively). FIU intensities for the whole islet were determined using Image-J and normalized to the FIU
baseline (intensity measured in the first time point) (B) Peak FIU intensities (FIUpeak) of the whole islets before and after glucose
injection (normalized to baseline FIU intensity measured in the first time point) (curves shown in (A) at different developmental
stages (3, 4 and 5 dpf) (n = 5, 3 and 8 larvae, respectively). (D) Peak FIU intensities (FIUpeak) of the whole islets in unstimulated larvae
(normalized to baseline FIU intensity measured in the first time point) (curves shown in (C)) at different developmental stages (3, 4
and 5 dpf) (n = 8, 8 and 6 larvae, respectively). FIU = Fluorescence Intensity Units (AU, Arbitrary Units).Data are shown as mean
values ±s.d., *p < 0.05 in one-way ANOVA, Tukey’s Multiple Comparison test to compare the glucose-injected groups (between 3, 4
and 5 dpf old larvae after glucose) in (B) and the unstimulated larvae in (D), and two-tailed, paired t-test was done to compare
before and after glucose groups in (B).
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Figure 4. Comparison of ex vivo and in vivo glucose responsiveness.
(A) Fluorescence image series of isolated pancreatic islet showing GCaMP6 signal alteration at the indicated time-points shown in (B)
applying 2 mM, 20 mM glucose and 30 mM KCl. Single β-cell is defined as ˜3 × 5 μm white rectangular selection drawn around one
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genetic roles of CaV1.2 and CaV1.3 in glucose
homeostasis are not well defined. Physiological
studies indicate that CaV1.2 and CaV1.3 are key
regulators of mammalian glucose-induced insulin
secretion (for a review, see ref.43), but correspond-
ing mouse knockout models displayed only minor
effects on insulin secretion and glucose homeosta-
sis, perhaps due to compensation by other chan-
nels. In particular, it was found that CaV1.2 in β-
cells is required for proper first-phase glucose-
induced insulin secretion, and that CaV1.3 may
modulate second-phase secretion, each of which
is significant for normal glucose tolerance.40,43
The zebrafish has three CaV1.2 and CaV1.3 encod-
ing gene orthologues, of which two – cacna1c
(encoding CaV1.2) and cacna1da (CaV1.3a) –
show expression in the developing pancreatic
islet.50–52 The third gene cacna1db (CaV1.3b) is
exclusively expressed in the central nervous
system.51 To test cell type specific expression of
CaV1.2 and CaV1.3a, we performed whole mount
stains in different endocrine GFP-reporter stains
(Sup. Fig. 4). We found that CaV1.2 and CaV1.3a
are expressed in all hormone-positive pancreatic
cells of embryos older than one day (Sup. Fig. 4.).
To determine requirements of these genes in glu-
cose homeostasis, we took advantage of previously
described mutants for CaV1.2 (isl, isl
m485, island
beat)50,53 and CaV1.3a (gem, gem
tc323d, gemini).-
54,55 Both mutant alleles carry premature stop
codons that result in the expression of truncated
(and most likely inactive) proteins. Measurements
of free glucose in control and mutant embryos
showed elevated glucose levels in 4–5 dpf CaV1.2/
islm458 (Figure 6(A) and Sup. Fig. 5) but normal
glucose levels in 5 dpf CaV1.3a/gem
tc323d mutants
(Sup. Fig. 6). These data suggest impaired β-cell
functionality in the CaV1.2/isl
m458 mutant fish.
To test whether CaV1.2/isl
m458 mutants affect β-
cell specific [Ca2+]i dynamics, the mutation was
crossed into the ins:lynGCaMP6s background. In
vivo fluorescence recordings of untreated 5 dpf
transgenic larvae showed significantly higher
basal islet [Ca2+]i dynamics in mutants than con-
trol animals (Figure 6(C), Sup. Video 3 and 4).
Hyperglycemia in these animals raised the possi-
bility that non-islet effects could underlie the
increased [Ca2+]i dynamics in the CaV1.2/isl
m458
mutants. To eliminate non-islet effects, we per-
formed ex vivo recordings of isolated mutant and
control islets. Importantly, increased [Ca2+]i
dynamics in mutants were maintained in isolated
islets and appeared to be glucose independent. In
particular, we found that in mutant islets the
change from 2 mM to 20 mM glucose had no
significant effect on the peak frequency (2 mM:
0.6 ± 0.3 and 2.6 ± 0.7 peaks/min; 20 mM:
6.0 ± 1.0 and 1.8 ± 0.5, control and mutant,
respectively) (Figure 6(C)), or on the integrated
signal intensity (2 mM: 0.018 ± 0.004 and
0.065 ± 0.008 AUC; 20 mM: 0.057 ± 0.013 and
0.074 ± 0.011, control and mutant, respectively)
(Figure 6(D) and Sup. Fig 7A), while in control
islets these parameters were significantly increased
piece of the GCamP6s-expressing membrane located between two individual β-cells. Scale bar = 10 µm. (B) Single cell GCaMP6s
fluorescence traces for isolated islet from wild-type zebrafish larvae (5 dpf) after applying 2 mM, 20 mM glucose followed by 30 mM
KCl. FIU intensities for the single cells (n = 6 cells) were determined using Image-J, normalized to the FIU baseline (intensities
measured in the first 2 min when 2 mM glucose was applied) and displayed as FIU/FIU baseline (AU) for single cells (coloured dotted
line) and for the average of the singles cells in the islet (black line). (C) Quantification showing the percentage of β-cells that respond
upon stimulation with 20 mM glucose, ex vivo and the percentage of glucose-responsive β-cell area after intravenous injection of
>10 mM glucose in vivo. (n = 8 and 9 larvae were analyzed, in vivo and ex vivo, respectively) (D) Average oscillation frequencies of 4
selected β-cell areas of the pancreatic islet (n = 8 islets, in each islet 4 β-cell areas were manually selected based on the red RFP
expression) after intravenous injection (~1–2 nl of 0.5 M glucose, >10 mM final concentration) of 5 dpf old zebrafish larvae (in vivo,
imaged by epifluorescence microscope), and average oscillation frequencies of individual β-cells (n = 5 islets, in each islet >6 cells
were analyzed) of the isolated pancreatic islets after 20 mM glucose stimulation (ex vivo, imaged by spinning disc microscope).
Oscillation peaks were identified by PeakCaller, MATLAB on the FIU/FIU baseline traces of individual β-cells/areas (see Sup. Fig. 2A).
The peak number was divided by the time duration until oscillation was observed (˜30–60 sec, in vivo, ˜150–300 sec, ex vivo) (E)
Cross-correlation matrix (determined by PeakCaller, MATLAB) of the islet between individual cells shown in (A) and (B), with color
key to the right of the matrix graph. Numbers on the x and y axes represent individual cells that are marked in (A) and (B). (F) Time
to peak calculated from the time point when addition of the new glucose solution was finished in isolated islets, ex vivo (n = 7 islets,
the addition took in average ˜38 seconds), and when glucose was injected in living zebrafish larvae, in vivo (n = 8 islets from n = 8
larvae). Data are shown as mean values ±s.e.m., *p < 0.05 in unpaired, two-tailed t-test between ex vivo and in vivo groups in (C), (D)
and (F). FIU = Fluorescence Intensity Units (AU, Arbitrary Units).
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Figure 5. Stimulation of β-cell by L-glutamine and palmitic acid.
Representative single cell GCaMP6s fluorescence traces for isolated islet from wild-type zebrafish larvae (5 dpf) after applying 2 mM
glucose followed by 20 mM L-glutamine (A), and 1 mM palmitic acid (B) stimulation and 30 mM KCl. FIU intensities for the single
cells (n = 10–10 cells) were determined using Image-J, normalized to the FIU baseline (intensities measured in the first 2 min when
2 mM glucose was applied) and displayed as FIU/FIU baseline (AU) for single cells (coloured dotted line) and for the average of the
singles cells in the islet (black line). Cross-correlation matrices (determined by PeakCaller, MATLAB) of the islets between individual
cells shown in (A) left panel and (B) left panel, with color key to the right of the matrix graph. Numbers on the x and y axes
represent individual cells. Cross-correlation analysis was done on the section where L-glutamine/palmitate stimulation was applied
(excluding KCl section). (C) Calcium responses to 20 mM L-glutamine and 1 mM palmitic acid when compared to 2 mM glucose. The
changes in GCaMP6s fluorescence intensity in β-cells of wild-type pancreatic islets were averaged for the whole islet and the FIU
peak intensity upon different nutrient stimulation was normalized to the FIU peak intensity upon KCl stimulation (n = 23, 7, 5, 4 and
7 islets were analyzed for 2 mM glucose, 20 mM glucose, 20 mM L-glutamine, 20 mM sucrose, and 1 mM palmitic acid stimulation,
respectively) (in each islet at least n = 5–8 cells were analyzed and the FIU peak intensity was measured in the average FIU trace for
the whole islet). Data are shown as mean values ±s.e.m., *p < 0.05 in unpaired t-test between 2 mM glucose and 20 mM sucrose,
20 mM L-glutamine, and 1 mM palmitic acid stimulation. FIU = Fluorescence Intensity Units (AU, Arbitrary Units).
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Figure 6. Ex vivo imaging of β-cells Ca2+i dynamics in CaV1.2 mutant zebrafish larvae.
(A) CaV1.2/isl
m458 mutant shows elevated whole larval glucose levels at 4 and 5 dpf. Glucose levels measured at 4 and 5 dpf whole
larval extracts (pool of 10–10 larvae), normalized to the protein level measured by Nanodrop, and showed as relative to the average
control value. (n = 4 and 8 biological replicates, respectively) (at 5 dpf, results combined from 2 independent experiments)
(***p < 0.0001, two-tailed t-test). (B) Fluorescence image series of an isolated islet from 5 dpf old CaV1.2 mutant crossed with ins:
lynGCaMP6s larva (upper panel). Quantitation of GCaMP signal intensity in the time series shown in the upper panel, indicating FIU/
FIU baseline changes after 20 mM glucose as well as after 30 mM KCl stimulation (lower panel). (C) Quantification of GCaMP6s
fluorescence intensity peaks determined by PeakCaller, MATLAB in vivo, without any stimulation (n = 6 wild type and 8 CaV1.2
mutant larva), and ex vivo, upon 2 and 20 mM glucose stimulation in wild-type and CaV1.2 mutant larva (n = 7–7 and 6–6 larvae,
respectively), shown as oscillation frequency (min−1) (peak number/cell number*minute). β-cell number was defined based on red
nuclei RFP expression in one focal plane (4–10 cells per islet were analyzed) (**p < 0.005, two-tailed, nonparametric Mann-Whitney
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by increasing glucose levels. Thus, there is a coun-
terintuitive increase in [Ca2+]i oscillations at basal
glucose in the mutant islets. In mouse, CaV1.3
subunit knockout was found to be compensated
by CaV1.2 upregulation.
42 To test whether upregu-
lation of CaV1.3a may account for the CaV1.2/isl-
m458 mutant phenotype, we performed RT-qPCR
(reverse transcriptase quantitative PCR) analyses.
However, transcripts levels for CaV1.2 and
CaV1.3a in whole embryos (Figure 6(E)) and iso-
lated islets (Figure 6(F)) showed no significant
differences between controls and mutants. These
data show that genetic loss of CaV1.2 results in
glucose-independent hyperactivation of β-cells,
and suggest that this activation is independent of
cell-autonomous compensatory effects.
Discussion
We have successfully assessed [Ca2+]i dynamics in
β-cells of zebrafish pancreatic islets, both in vivo
after injection of glucose and ex vivo using per-
fused isolated islet. We found that zebrafish β-cells
are directly glucose-responsive, and that respon-
siveness is established early in embryonic develop-
ment. These data are consistent with a conserved
glucose sensing and stimulus-secretion coupling
mechanism in fish and mammals. However, our
analyses also showed that glucose-induced β-cell
responses in perfused embryonic zebrafish islets
are not well-synchronized, while β-cells in per-
fused mammalian islets show well-synchronized
[Ca2+]i oscillations throughout the whole islet.
56–
58 In agreement with very recent ex vivo Ca2+
recordings of perfused juvenile zebrafish islet,39
the data suggest that zebrafish islets are uncoupled,
at least in the developing zebrafish.
We also evaluated different approaches for glu-
cose administration in living zebrafish embryos. It is
important to note that our in vivo imaging data, in
contrast to the ex vivo data, did not allow analyses at
single cell resolution. The combination of the deep
tissue localization, the frequent presence of light
absorbing pigment cells, and permanent slow tissue
movements due to gut peristaltic movement pre-
vented more detailed analyses. However, our data
revealed that embryonic in vivo β-cell responses are
immediate and synchronized when glucose is
directly injected into the bloodstream, and that gra-
dually increasing blood glucose levels result in
delayed, non-synchronized [Ca2+]i fluctuations,
very similar to those found in glucose-stimulated
perfused islets. Currently, we can only speculate
about the mechanism underlying the synchronized
responses after intravenous glucose injection.
Possibly, the synchronicity is caused by a cell-auton-
omous but simultaneous response of all β-cells to the
simultaneous prompt exposure to a high glucose
challenge. Alternatively, synchronicity could be trig-
gered by a currently undefined paracrine signal. In
this context, the much faster [Ca2+]i dynamics in
living animals, as compared to isolated islets, could
indicate the involvement of neuronal driven triggers.
Consistent with this possibility, it was recently
shown that the embryonic zebrafish islet is inner-
vated at the relevant time points, and that a neuro-
transmitter, namely galanin expressed in these
neurons, is involved in blood glucose regulation.59,60
Notably, the delayed glucose response in the isolated
zebrafish islets is similar to that seen in mammalian
islets. While this delay is attributed to the time taken
for glucose diffusion andmetabolism,61,62 it might be
further affected by the cleavage of neural connection
during the islet isolation procedure.60 Measurements
of real-time glucose response of pancreatic mouse
islets by autofluorescenceNAD(P)H signals also sug-
gests that there might be differences in glucose meta-
bolism after isolation.63 However, the time to reach
the initial GCaMP fluorescence peak after glucose
injection in mice in vivo (~1–2 minutes) is still much
test) (D) Quantification of GCaMP6s fluorescence intensity ex vivo in wild-type and CaV1.2 mutant larvae shown as area under curve
(AUC) upon 2 mM and 20 mM glucose stimulation normalized to the treatment duration (n = 9 and 10 larvae, respectively)
(***p < 0.0005, two-tailed, unpaired t-test). (E) Relative normalized CaV1.2 and CaV1.3a mRNA expression levels as determined by RT-
qPCR (reverse transcriptase quantitative PCR) in 5 dpf old wild type and CaV1.2 mutant larvae (pools of 15 whole larvae) (n = 3
biological replicates, 2 technical replicates) (F) Relative normalized CaV1.2, CaV1.3a, insulin and neuroD mRNA expression levels
determined by RT-qPCR in isolated pancreatic islets from 5 dpf old wild type and CaV1.2 mutant larva (pools of 15 islets) (n = 3
biological replicates, 2 technical replicates). Data are shown as mean values ±s.e.m (*p < 0.05, two-tailed t-test). FIU = Fluorescence
Intensity Units (AU, Arbitrary Units).
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slower than in our study in zebrafish (˜5 sec).35
Therefore, we also cannot exclude the possibility
that the fast response in zebrafish is caused by
bypassing glucose metabolism, with glucose activat-
ing [Ca2+]i by other mechanisms, such as the swel-
ling-sensing LRRC8 channels, for example, similar
to mouse β-cells.64 Detailed analyses is required to
investigate the potential function of the LRRC8 pro-
teins in zebrafish β-cells, but expression profiling of
zebrafish islets cells suggests that the 5 lrrc8 genes are
differentially expressed between these cell types.52,65
Our finding that both palmitate and
L-glutamine resulted in elevated [Ca2+]i correlates
with increased Ca2+ signalling and insulin secre-
tion in mammalian islets exposed to free fatty
acids and amino acids. However, and in contrast
to mammalian islets, zebrafish embryonic islets
did not require the simultaneous presence of glu-
cose for elevated [Ca2+]i signals.
47,66,67
Our studies further reveal a novel central role of
CaV1.2 in β-cell specific stimulus-secretion cou-
pling in zebrafish. We find that genetic loss of
CaV1.2 but not of CaV1.3a, results in elevated
glucose level during development. Further, we
show that β-cells in CaV1.2/isl
m458 mutant zebra-
fish display increased basal [Ca2+]i and a complete
loss of glucose-responsiveness. Future studies will
be required to unravel the underlying mechanism
of the increased basal activity of the CaV1.2 trun-
cated β-cells. The counterintuitive increase in [Ca2
+]i oscillations at basal glucose in the mutant cells
could be caused by an overcompensation of other
VDCCs, as was seen in CaV1.3 knockout mice.
42
While our qPCR analyses revealed no evidence for
up-regulation of CaV1.2 and CaV1.3a, this does
not exclude the possibility of dysregulation of
other Ca2+ channels (N-, P/Q-type), that might
be expressed and functional in the zebrafish islet.52
Importantly, our studies also suggest that β-cell
specific CaV1.2 functions might be very different
in zebrafish and mice. Notably, CaV1.2 mutant
mice are not viable and therefore comparable
embryonic β-cell defects have not been determined
in the mouse mutants.68 However, β-cell specific
loss of CaV1.2 has only moderate effects on [Ca
2+]i
handling and glucose responsiveness in mice,
despite significantly reduced CaV currents and
inhibition of first-phase insulin secretion.40 The
expression of CaV1.2 not only in β-cells but rather
in all pancreatic endocrine cells leaves other pos-
sibilities for non-cell autonomous β-cell defects
due to paracrine effects such as dysfunctional α-
or δ-cells. A disturbed intra-islet communication
(for a review see ref.69) could explain why β-cell
phenotypes in CaV1.2/isl
m458 mutants appear to be
completely different from those seen in β-cell spe-
cific CaV1.2 knock-out mice.
Our demonstration of glucose-dependence of
[Ca2+]i provides support for zebrafish as an appro-
priate model to study stimulus-secretion coupling
in the pancreas, both for fundamental understand-
ing of secretion control, and for development of
novel approaches to β-cell related diseases.
However, in defining distinct consequences of
manipulation of the voltage-gated L-type Ca2+
channel, our work also highlights the need to
determine underlying differences between mam-
malian and zebrafish β-cell physiology to better
understand this framework for applying zebrafish
as a diabetes model.
Materials and methods
Zebrafish breeding and maintenance
Zebrafish (Danio rerio) were maintained according
to standard protocols.70 Developing embryos were
staged by hours post fertilization (hpf) when incu-
bated at 28°C.71 All procedures were approved by
the Austrian Bundesministerium für Wissenchaſt
und Forschung (GZ BMWFW-66.008/0004-WF/
II/3b/2014).
Construction of Tg[ins:lynGCaMP6s,ins:H2B:RFP]
The lyn membrane tag sequence was PCR-ampli-
fied from pcDNA8D3cpv (Addgene plasmid
#36323; Primer1: 5′TGGGATCCCCACCATGGG
CTGCATCA-3′; Primer 2: 5′-TCTCTAGACCGG
TATCGGGTGGATCGATTCTCAGTTTGGGT-
GGGGTCTTCATGTCCACGC-3′) and ligated
into the pME vector using the BamHI and XbaI
sites. Subsequently, the GCaMP6s sequence from
Tol2 HuC GCaMP6s vector were added using
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Age1 sites for ligation. The final construct was
assembled by 4-fragment Gateway cloning (LR
Clonase II Enzyme mix; Invitrogen, 11–791-100)
using pDestTol2CG2 ins:H2B-RFP (Addgene
plasmid), p5E insulin promoter, p3E polyA and
the pME lynGCaMP6s plasmids.
Immunohistochemistry
Immunostaining of whole embryos or larvae was
performed as previously described.72 Larvae were
collected at 5 dpf, and fixed for 2 hours at room
temperature in 4% PFA/1% DMSO in PBS, then
washed 3 × 5 minutes with 1 × PBS/0.1% Tween.
Zebrafish embryos were incubated for one hour in
blocking solution (PBS/1%DMSO/1%BSA/1%
Triton), then incubated overnight at 4°C with pri-
mary antibodies diluted in blocking solution.
Afterwards, washing was conducted with PBS+0.2%
Triton. Primary antibodies and dilutions were: gui-
nea pig anti-insulin (1:200, Dako, A0564), rabbit
anti-GFP (1:200, Torrey Pines Biolabs,
NC9589665). Secondary antibodies (1:1000 dilution)
were Alexa-conjugated (Invitrogen). Embryos were
washed and then reblocked, and incubated in sec-
ondary antibody overnight at 4°C.
Whole-mount in situ hybridization (WISH)
WISH was performed as described previously.73
Antisense probes were Digoxigenin (DIG RNA
Labeling Mix, Roche, 11277073910) labelled and
visualized with α-Digoxigenin-AP antibody
(1:4000, Roche, 11093274910). The following
probes were used:
CaV1.2: CaV1.2 Xba S: GGACAACTTTG
ACTATTTAACACGG; CaV1.2_R: CTGTTCCC
CCTACAAACTCG
CaV1.3a: CaV1.3a 5′ S: CTGAAAGGAAAGA
CCTCATCAAAGAG, CaV13a_R: ACCAGGTGC
TATAAAGTGGTAAT
All antisense RNA probes were generated by
linearization of the corresponding plasmids and
transcription was performed using T3, T7 or SP6
RNA polymerase. The eGFP of transgenic ani-
mals was visualized by immunostaining after the
in situ hybridisation. Primary antibody: anti-
GFP rabbit (1:200, Abcam, ab6556); secondary
antibody: Alexa Fluor 488 goat anti-rabbit
(1:1000, Roche, A32731). Immunostainings
were performed as described above.
In vivo glucose injection and imaging
Larvae (3, 4 and 5 dpf) for live imaging were
anesthetized using cold-shock (embryos in egg
water-containing dishes are set directly on ice)
and immobilized by injection of ~10 nl of 1 mg/
ml purified α-bungarotoxin (BTX, B137, Sigma-
Aldrich, T9641) either to the yolk or to the gut.
After 10–15 minutes, embryos were embedded
in 1.2 % low melt agarose and imaged either on
a Leica DM6000B microscope equipped with a
SPOT-RT3 digital camera (Diagnostic
Instruments, Inc., Sterling Heights, MI) (intrave-
nous injection) or on a Zeiss Cell Observer SD
using a 25X water immersion objective (brain,
yolk, pericardium injection). Time lapse images
were collected with 500 ms–1000 ms time inter-
vals, 50–100 ms exposure for GCaMP6s, and
150 ms for RFP, 2 × 2 binning. For adjusting
the needle (GB120F-10, 69 × 1,20 × 100 mm
with filament, Science Products GmbH) into
the dorsal aorta, or into the hindbrain ventricle,
yolk and pericardium, 5X or 10X dry objectives,
and for intravenous injection of ~1–2 nl of
0.5 M glucose (Carl Roth GmBH) (final concen-
tration of ~10–20 mM, assuming the blood
volume of zebrafish embryo is 60 nl) (79) in
combination with 1.25% Rhodamine B isothio-
cyanate-Dextran (R9379, Sigma-Aldrich) to con-
firm intravenous injection, 40X water objective
was used (Sup.Video 1). In vivo imaging of
hindbrain ventricle, yolk, pericardium glucose
injection (˜9 nl of 1 M glucose in combination
with 1.25% Rhodamine B isothiocyanate-
Dextran, final concentration of ˜30 mM, assum-
ing the total volume of a 5 dpf old larva is
300 nl),74 unstimulated larvae and CaV1.2/isl
mutants crossed with ins:lynGCaMP6s was car-
ried out with a Zeiss Cell Observer SD spinning




Zebrafish embryos at 5 dpf were euthanized using
cold-shock, rolled onto their left sides and, using
26 G sterile hypodermic-needles, yolk and visc-
eral organs were removed by applying gentle
pressure using needles until fully separated. The
islets were identified and confirmed by either
GCaMP6s green fluorescence or RFP red fluores-
cence. Not all of the islet surrounding tissue was
removed in order to avoid the collapse of the
islet. Freshly dissected islets were transferred by
glass pipette to RPMI (ThermoFisher 11875–093)
supplemented with 1 mM HEPES, antibiotic solu-
tion (Sigma A5955, 10 mll−1 solution), 10% fetal
bovine serum and diluted with glucose-free RPMI
to final glucose concentration of 6.67 mM (zebra-
fish islet media) in a 12-wells culture plate. Islets
were incubated at 28°C for 1.5–2 hours before
imaging.
Glucose level measurement
Glucose levels in whole larvae were measured
using Glucose Assay Kit (BioVision, K606-100)
as previously described.75 In brief, pools of 10
whole larvae were collected in 200 µl cold PBS,
and lysed by glass bead (0.5 mm) homogenization
in Precellys24 bead homogenizer (one cycle of 20 s
at 5000 rpm) (Peqlab). After centrifugation (10,
000 rpm for 30 s at 4°C), supernatants were trans-
ferred into fresh tubes, and glucose assay was
carried out according to manufacturer’s recom-
mendation. In all experiments, at least 3 biological
replicates (10 whole larvae), and 2 technical repli-
cates were measured.
Ex vivo imaging
Islets from ins:lynGCaMP6s were placed into
glass-bottomed culture plates containing 2 mM
glucose solution (2 mM glucose in KRBH salt
solution: 114 mM NaCl, 4.7 mM KCl, 1.16 mM
MgSO4 heptahydrate, 1.2 mM KH2PO4, 2.5 mM
CaCl2 dihydrate, 5 mM NaHCO3, 20 mM HEPES
and 0.1 g/100 ml BSA) with agarose gel wells.
Islets were imaged on a Zeiss Cell Observer SD
using a 40X water immersion objective (time
lapse with 500 ms-1 s time interval, 50 ms
exposure for GCaMP6s) while indicated solutions
were changed using a handmade perfusion sys-
tem (5 ml syringes connected to plastic tubes
through 26 G needles). Salts and glucose were
purchased from either Roth GmbH or
AppliChem GmbH. Solutions containing 2 mM
and 20 mM glucose, 20 mM L-glutamine
(Thermo Fischer, 25030081), 1 mM palmitic
acid (sodium salt, 98%, Thermo Fischer,
416700050) and 30 mM KCl were used.
Image analysis
Visiview soſtware (Visitron Systems, Puchheim,
Germany) (for in vivo intravenous glucose injection
experiments) and ZEN software (for ex vivo experi-
ments and in vivo brain, yolk, pericardium injection)
were used to capture time lapses, and fluorescence
images were processed using ImageJ (Fiji) ROI
Analyzer.76 StackReg plugin in the ImageJ/Fiji was
used for the recursive alignment of time series, as
previously described.77 The ROI manager in ImageJ/
Fiji was used to manually draw either rectangular
selection (~3 × 5 μm) around one piece of the
GCaMP6s-expressing membranes located between
two individual β-cells (referred as single β-cell, in ex
vivo experiments done by Zeiss spinning disc micro-
scopy), or polygon selections around the whole islet or
4 non-overlapping single-cell sized β-cell areas per
islet that were defined based on red nuclei RFP
expression (called as β-cell area) (in vivo experiments
done by Leica epifluorescence microscopy) to mea-
sure the mean GCaMP6s fluorescence intensity (FIU)
for each time frame. The mean GCaMP6s FIU per β-
cell/β-cell area or per islet was normalized to the
baseline (which is calculated as the mean intensity
during incubation in 2mM glucose for ex vivo experi-
ments, and as the intensity in the first time point for in
vivo experiments) and displayed as FIU/FIU baseline
trace (Arbitrary Unit, AU) over time (sec or min). To
correct for fluorescence decay due to photo bleaching,
non-linear regression analysis (2 phase exponential
decay, without weight data points and fixing of para-
meters) was carried out using GraphPad Prism ver-
sion 5.00 for Windows (GraphPad Software, La Jolla,
California USA, www.graphpad.com). Total β-cell
[Ca2+]i dynamics (ex vivo) was quantified by two
different methods, either by calculating the area
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under the curve (AUC) as described previously,35 or
for quantitative curves in Figure 5(C) and Sup. Fig. 7,
the glucose and other nutrient (sucrose, L-glutamine,
palmitic acid) responses are shown normalized to the
change in fluorescence in response to KCl (showing
maximum islet depolarization), because the maxi-
mum excitability of an islet or β-cell can vary, and
the intensity of the islet’s fluorescence can also vary.
For AUC analysis, we calculated the average of the
single FIU/FIU baseline traces for 2 min before sti-
mulation (basal [Ca2+]i dynamics), and 6 min after
20 mM glucose stimulation (stimulated [Ca2+]i
dynamics), and normalized to the treatment duration
(Figure 6(D)). For calculating the fraction of high
glucose-responsive area (Figure 4(C)), the Ca2+ influx
response was defined as positive when the normalized
GCaMP6s FIU within the selected β-cell area (in vivo)
or single β-cell (ex vivo) showed >7% increase in
comparison to the time point before glucose injection
or 20 mM glucose stimulation, and this increase in
fluorescence intensity was higher than the peak fluor-
escence intensity at baseline. In all ex vivo experi-
ments, β-cells that failed to show fluorescence
increase (>7% compared to time point before stimu-
lation) upon KCl stimulation were excluded from
quantification. Cross-correlation analysis (Fig. 4(E),
5(A,B), Sup. Fig. 2B, 3) and identification of the
peak numbers for oscillation frequencies (Figures 4
(D) and 6(C)) on the FIU/FIU baseline traces of
individual β-cells/areas were done by PeakCaller in
MATLAB78 (required rise: 1%, required fall: 3%, max.
lookback: 5 pts, max. lookahead: 5 pts) Cross-correla-
tion analysis was done on the section where glucose
stimulation was applied (excluding KCl section).
Oscillation frequencies (min−1) are average peak
number per minute of selected β-cells (>6 cells, ex
vivo) or β-cell areas (4 non-overlapping single-cell
sized selected region based on RFP red expression,
in vivo) normalized to the time duration until oscilla-
tion was observed in the time series (˜30–60 sec, in
vivo, ˜150–300 sec, ex vivo).
qPCR
Total RNAwas prepared from dissected islets of 5 dpf
old zebrafish larvae (pool of 15 islets) and from whole
zebrafish larvae (pool of 15 larvae) using Trizol
(Ambion), cDNA was prepared using the First
Strand cDNA synthesis kit (Thermo Scientific).
qPCR was performed in a CFX Connect Real-Time
System (BioRad) using the HOT Fire-Pol EvaGreen
qPCR Mic Plus (Solis BioDyne). Data shown is the
average of 3 biological replicates, presented as gene
expression level relative to controls, after normaliza-
tion to the housekeeping gene ef1alpha. PCR primer
pairs for CaV1.2 (5′ to 3′): TCTTCA
GGTGTGCGACAGGA (F), CTTCTCACAAGGG
CGGTTTG (R), CaV1.3a: CCTCAGGCTGT
GCTTCTGCT (F), CACAGCTTGCCTGGCATA
CA (R), insulin: GCCCAACAGGCTTCTTCTAC
AAC (F), GCAGATTTAGGAGGAAGGAAACCC
(R), neuroD: CTTTCAACACACCCTAGAGTTCC




Graphical and statistical analyses were performed
using GraphPad Prism version 5.00 for Windows,
GraphPad Software, La Jolla, California USA, www.
graphpad.com. Significance was tested using two-
tailed distribution and either t-test or ONE-way
ANOVA analysis with p < 0.05 considered significant.
Data presented are generally representative of at least
three independent experiments (except as indicated).
Error bars represent standard error (s.e.m) (except as
indicated).
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